56 related articles for article (PubMed ID: 23296041)
1. A low-density DNA microchip for the detection of (anti-)estrogenic compounds and their relative potencies.
Wang S; Rijk JC; Pen MJ; Aarts JM; Peijnenburg AA; Rietjens IM; Bovee TF
Anal Biochem; 2013 Apr; 435(1):83-92. PubMed ID: 23296041
[TBL] [Abstract][Full Text] [Related]
2. Screening for estrogenicity and anti-estrogenicity: a critical evaluation of an MVLN cell-based transactivation assay.
Freyberger A; Schmuck G
Toxicol Lett; 2005 Jan; 155(1):1-13. PubMed ID: 15585354
[TBL] [Abstract][Full Text] [Related]
3. Proliferation assays for estrogenicity testing with high predictive value for the in vivo uterotrophic effect.
Wang S; Aarts JM; Evers NM; Peijnenburg AA; Rietjens IM; Bovee TF
J Steroid Biochem Mol Biol; 2012 Feb; 128(3-5):98-106. PubMed ID: 22138011
[TBL] [Abstract][Full Text] [Related]
4. Molecular identification of ERalpha-positive breast cancer cells by the expression profile of an intrinsic set of estrogen regulated genes.
Weisz A; Basile W; Scafoglio C; Altucci L; Bresciani F; Facchiano A; Sismondi P; Cicatiello L; De Bortoli M
J Cell Physiol; 2004 Sep; 200(3):440-50. PubMed ID: 15254972
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling in Ishikawa cells: a fingerprint for estrogen active compounds.
Boehme K; Simon S; Mueller SO
Toxicol Appl Pharmacol; 2009 Apr; 236(1):85-96. PubMed ID: 19371625
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of esculetin and daphnetin on in vitro cell proliferation and in vivo estrogenicity.
Jiménez-Orozco FA; Rosales AA; Vega-López A; Domínguez-López ML; García-Mondragón MJ; Maldonado-Espinoza A; Lemini C; Mendoza-Patiño N; Mandoki JJ
Eur J Pharmacol; 2011 Oct; 668(1-2):35-41. PubMed ID: 21741969
[TBL] [Abstract][Full Text] [Related]
7. Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists.
Wilson VS; Bobseine K; Gray LE
Toxicol Sci; 2004 Sep; 81(1):69-77. PubMed ID: 15166400
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor gamma in human breast carcinoma: a modulator of estrogenic actions.
Suzuki T; Hayashi S; Miki Y; Nakamura Y; Moriya T; Sugawara A; Ishida T; Ohuchi N; Sasano H
Endocr Relat Cancer; 2006 Mar; 13(1):233-50. PubMed ID: 16601291
[TBL] [Abstract][Full Text] [Related]
9. Extraction-dependent effects of American ginseng (Panax quinquefolium) on human breast cancer cell proliferation and estrogen receptor activation.
King ML; Adler SR; Murphy LL
Integr Cancer Ther; 2006 Sep; 5(3):236-43. PubMed ID: 16880429
[TBL] [Abstract][Full Text] [Related]
10. Performance of the flow cytometric E-screen assay in screening estrogenicity of pure compounds and environmental samples.
Vanparys C; Depiereux S; Nadzialek S; Robbens J; Blust R; Kestemont P; De Coen W
Sci Total Environ; 2010 Sep; 408(20):4451-60. PubMed ID: 20633926
[TBL] [Abstract][Full Text] [Related]
11. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
Pink JJ; Jordan VC
Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
[TBL] [Abstract][Full Text] [Related]
12. Estrogenic activities of sesame lignans and their metabolites on human breast cancer cells.
Pianjing P; Thiantanawat A; Rangkadilok N; Watcharasit P; Mahidol C; Satayavivad J
J Agric Food Chem; 2011 Jan; 59(1):212-21. PubMed ID: 21141889
[TBL] [Abstract][Full Text] [Related]
13. The pyrethroid metabolites 3-phenoxybenzoic acid and 3-phenoxybenzyl alcohol do not exhibit estrogenic activity in the MCF-7 human breast carcinoma cell line or Sprague-Dawley rats.
Laffin B; Chavez M; Pine M
Toxicology; 2010 Jan; 267(1-3):39-44. PubMed ID: 19853000
[TBL] [Abstract][Full Text] [Related]
14. Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships.
Connor K; Ramamoorthy K; Moore M; Mustain M; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P
Toxicol Appl Pharmacol; 1997 Jul; 145(1):111-23. PubMed ID: 9221830
[TBL] [Abstract][Full Text] [Related]
15. Anti-proliferative effect of estrogen in breast cancer cells that re-express ERalpha is mediated by aberrant regulation of cell cycle genes.
Moggs JG; Murphy TC; Lim FL; Moore DJ; Stuckey R; Antrobus K; Kimber I; Orphanides G
J Mol Endocrinol; 2005 Apr; 34(2):535-51. PubMed ID: 15821115
[TBL] [Abstract][Full Text] [Related]
16. Investigations on cellular proliferation induced by zearalenone and its derivatives in relation to the estrogenic parameters.
Minervini F; Giannoccaro A; Cavallini A; Visconti A
Toxicol Lett; 2005 Dec; 159(3):272-83. PubMed ID: 15994033
[TBL] [Abstract][Full Text] [Related]
17. Detection of weak estrogenic flavonoids using a recombinant yeast strain and a modified MCF7 cell proliferation assay.
Breinholt V; Larsen JC
Chem Res Toxicol; 1998 Jun; 11(6):622-9. PubMed ID: 9625730
[TBL] [Abstract][Full Text] [Related]
18. Hydroxylated polychlorinated biphenyl metabolites are anti-estrogenic in a stably transfected human breast adenocarcinoma (MCF7) cell line.
Kramer VJ; Helferich WG; Bergman A; Klasson-Wehler E; Giesy JP
Toxicol Appl Pharmacol; 1997 Jun; 144(2):363-76. PubMed ID: 9194421
[TBL] [Abstract][Full Text] [Related]
19. (Anti)estrogenic effects of phytochemicals on human primary mammary fibroblasts, MCF-7 cells and their co-culture.
van Meeuwen JA; Korthagen N; de Jong PC; Piersma AH; van den Berg M
Toxicol Appl Pharmacol; 2007 Jun; 221(3):372-83. PubMed ID: 17482226
[TBL] [Abstract][Full Text] [Related]
20. Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation.
Jeng MH; Parker CJ; Jordan VC
Cancer Res; 1992 Dec; 52(23):6539-46. PubMed ID: 1423300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
